Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions

Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions

Objectives. Level 1 evidence supports the use of neoadjuvant chemotherapy (NAC) to improve overall survival in muscle invasive bladder cancer; however utilization rates remain low. The aims of our study were to determine factors associated with NAC use, to more clearly define reasons for low utiliza...

Full description

Saved in:
Bibliographic Details
Main Authors: N. G. Cowan, Y. Chen, T. M. Downs, B. H. Bochner, A. B. Apolo, M. P. Porter, J. C. La Rochelle, C. L. Amling, T. M. Koppie
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Advances in Urology
Online Access:http://dx.doi.org/10.1155/2014/746298
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items